TARA
Protara Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.60 / 10
Netural
Sentiment is neutral (3.6/10) but fund‑flow score is strong at 7.21, with modest overall inflow yet negative trends for most block sizes; only small investors are net positive. Analyst coverage is limited to one Buy rating, historically yielding –19% return, indicating weak confidence.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-04
InstitutionJP Morgan
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for TARA?
- TARA holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.60/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
